The FDA had uncertainty about the degree of clinical benefit for Novocure’s treatment of brain metastases, the company said.

The first-of-its-kind transcatheter device treats paravalvular leak after valve replacement surgery, to spare the patient ...

Edwards’ TAVR device in moderate aortic stenosis drew applause from meeting attendees, while Medtronic’s renal denervation ...

CEO Ivan Tornos did not attribute the company’s performance in knees to a broader market slowdown, as competitor Stryker did ...

The medical device company’s stock dropped when the market opened Wednesday after it slashed sales and earnings forecasts ...

CEO Kevin Lobo said the slowdown in hip and knee procedures is tied to broader economic concerns. The outgoing CEO also ...

The CEO change was unexpected and prompted a stock selloff Friday, analysts said, but the new chief executive is prepared for ...

The company notified customers this month that it will discontinue Medline brand beds and associated products and exit the ...

M&A rose, but company valuations declined in the first half of 2026 compared with the year-ago period, according to EY’s ...

Patients, providers and medtech firms submitted hundreds of comments to the Food and Drug Administration on how the agency ...

The testing service providers hope the legislation, which would reform the CMS’ reimbursement rate-setting process, can cross ...

Abbott and Dexcom, market leaders for continuous glucose monitors, are focusing on insurance coverage and pricing ahead of a ...